Spectrum Pharmaceuticals Net Income 2006-2019 | SPPI

Spectrum Pharmaceuticals net income from 2006 to 2019. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Spectrum Pharmaceuticals Annual Net Income
(Millions of US $)
2019 $-113
2018 $-121
2017 $-92
2016 $-70
2015 $-53
2014 $-46
2013 $-62
2012 $94
2011 $50
2010 $-47
2009 $-19
2008 $-14
2007 $-22
2006 $-23
2005 $-19
Spectrum Pharmaceuticals Quarterly Net Income
(Millions of US $)
2019-12-31 $-39
2019-09-30 $-26
2019-06-30 $-28
2019-03-31 $-19
2018-12-31 $-50
2018-09-30 $-69
2018-06-30 $14
2018-03-31 $-16
2017-12-31 $-29
2017-09-30 $-18
2017-06-30 $-21
2017-03-31 $-24
2016-12-31 $-19
2016-09-30 $-17
2016-06-30 $-24
2016-03-31 $-9
2015-12-31 $-6
2015-09-30 $-19
2015-06-30 $-2
2015-03-31 $-26
2014-12-31 $-3
2014-09-30 $-12
2014-06-30 $-4
2014-03-31 $-28
2013-12-31 $-39
2013-09-30 $-8
2013-06-30 $-10
2013-03-31 $-5
2012-12-31 $7
2012-09-30 $22
2012-06-30 $18
2012-03-31 $47
2011-12-31 $10
2011-09-30 $20
2011-06-30 $7
2011-03-31 $13
2010-12-31 $6
2010-09-30 $-5
2010-06-30 $-10
2010-03-31 $-39
2009-12-31 $10
2009-09-30 $0
2009-06-30 $-30
2009-03-31 $0
2008-12-31 $-7
2008-09-30 $-9
2008-06-30 $11
2008-03-31 $-9
2007-12-31 $-0
2007-09-30 $-7
2007-06-30 $-6
2007-03-31 $-8
2006-12-31 $-1
2006-09-30 $-7
2006-06-30 $-9
2006-03-31 $-6
2005-12-31 $-4
2005-09-30 $-5
2005-06-30 $-5
2005-03-31 $-5
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.261B $0.109B
Spectrum Pharmaceuticals, Inc. is opportunistically acquiring and advancing a diversified portfolio of oncology drug candidates that meet critical health challenges for which there are few other treatment options. Spectrum's expertise lies in identifying undervalued drugs with demonstrated safety and efficacy, and adding value through further clinical development and selection of the most viable and low-risk methods of commercialization. The company's pipeline includes promising early and late-stage drug candidates with unique formulations and mechanisms of action that address the needs of seriously ill patients, such as at-home chemotherapy and new treatment regimens for refractory disease.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $55.415B 32.06
Takeda Pharmaceutical (TAK) Japan $49.277B 8.64
Astellas Pharma (ALPMY) Japan $30.146B 15.06
Eisai (ESALY) Japan $21.608B 40.25
UCB SA (UCBJF) Belgium $16.296B 0.00
Grifols, S.A (GRFS) Spain $14.164B 17.61
Merck (MKGAF) Germany $13.525B 17.74
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Neurocrine Biosciences (NBIX) United States $8.453B 234.85
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.874B 0.00
Catalent (CTLT) United States $7.387B 30.39
Ionis Pharmaceuticals (IONS) United States $6.712B 20.34
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.721B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.591B 6.82
Orion OYJ (ORINY) Finland $5.269B 23.61
STADA ARZNEIMI (STDAF) Germany $4.685B 0.00
Forty Seven (FTSV) United States $4.593B 0.00
IPSEN SA ADR (IPSEY) France $4.511B 0.00
United Therapeutics (UTHR) United States $4.260B 0.00
Hypermarcas (HYPMY) Brazil $3.661B 11.14
Evotec AG (EVTCY) Germany $3.485B 56.21
Nektar Therapeutics (NKTR) United States $3.207B 0.00
FibroGen (FGEN) United States $3.083B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.945B 54.66
PTC Therapeutics (PTCT) United States $2.664B 0.00
ChemoCentryx (CCXI) United States $2.441B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.391B 9.67
Xencor (XNCR) United States $1.736B 70.88
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.651B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.634B 19.86
Sage Therapeutics (SAGE) United States $1.531B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.453B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.417B 38.75
Corcept Therapeutics (CORT) United States $1.341B 15.00
Karyopharm Therapeutics (KPTI) United States $1.312B 0.00
USANA Health Sciences (USNA) United States $1.249B 13.11
Zogenix (ZGNX) United States $1.161B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.103B 0.00
Heron Therapeutics (HRTX) United States $1.056B 0.00
Akebia Therapeutics (AKBA) United States $1.034B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.010B 31.29
Esperion Therapeutics (ESPR) United States $0.935B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.919B 12.79
Endo (ENDP) Ireland $0.830B 1.53
Translate Bio (TBIO) United States $0.689B 0.00
Tilray (TLRY) Canada $0.688B 0.00
Molecular Templates (MTEM) United States $0.643B 0.00
Aerie Pharmaceuticals (AERI) United States $0.626B 0.00
ImmunoGen (IMGN) United States $0.619B 0.00
Radius Health (RDUS) United States $0.606B 0.00
Collegium Pharmaceutical (COLL) United States $0.580B 0.00
Portola Pharmaceuticals (PTLA) United States $0.568B 0.00
Indivior (INVVY) United States $0.464B 2.76
Catalyst Pharmaceuticals (CPRX) United States $0.401B 13.38
Corbus Pharmaceuticals Holdings (CRBP) United States $0.399B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.398B 16.35
Siga Technologies (SIGA) United States $0.396B 0.00
Innate Pharma SA (IPHYF) France $0.385B 0.00
Ardelyx (ARDX) United States $0.380B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.371B 0.00
Organogenesis Holdings (ORGO) United States $0.357B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.327B 0.00
Trillium Therapeutics (TRIL) Canada $0.323B 0.00
Flexion Therapeutics (FLXN) United States $0.317B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.307B 0.00
Lannett Co Inc (LCI) United States $0.304B 4.89
Harpoon Therapeutics (HARP) United States $0.294B 0.00
DURECT (DRRX) United States $0.294B 0.00
Calithera Biosciences (CALA) United States $0.294B 0.00
TherapeuticsMD (TXMD) United States $0.291B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.279B 0.00
Concert Pharmaceuticals (CNCE) United States $0.269B 0.00
Ocular Therapeutix (OCUL) United States $0.260B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.258B 0.00
CASI Pharmaceuticals (CASI) United States $0.207B 0.00
OptiNose (OPTN) United States $0.197B 0.00
Recro Pharma (REPH) United States $0.187B 0.00
Rafael Holdings (RFL) United States $0.179B 0.00
Jounce Therapeutics (JNCE) United States $0.170B 3.06
Nature's Sunshine Products (NATR) United States $0.162B 20.24
PROFOUND MEDICL (PROF) Canada $0.157B 0.00
MEI Pharma (MEIP) United States $0.153B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.138B 0.00
Taiwan Liposome (TLC) Taiwan $0.137B 0.00
KalVista Pharmaceuticals (KALV) United States $0.135B 0.00
VAXART, INC (VXRT) United States $0.120B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.113B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.102B 0.00
Redhill Biopharma (RDHL) Israel $0.096B 0.00
CannTrust Holdings (CTST) Canada $0.090B 0.00
IMV INC (IMV) Canada $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.088B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.087B 0.00
Champions Oncology (CSBR) United States $0.083B 0.00
Xeris Pharmaceuticals (XERS) United States $0.082B 0.00
Aquestive Therapeutics (AQST) United States $0.076B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.076B 0.00
Hemispherx BioPharma (AIM) United States $0.076B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.074B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Biomerica (BMRA) United States $0.071B 0.00
CTI BioPharma (CTIC) United States $0.066B 0.00
Otonomy (OTIC) United States $0.064B 0.00
CV Sciences (CVSI) United States $0.062B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.056B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.055B 17.29
ALLERGY THERAPT (AGYTF) United Kingdom $0.055B 0.00
Infinity Pharmaceuticals (INFI) United States $0.048B 0.00
Nivalis Therapeutics (ALPN) United States $0.046B 0.00
PharmAthene (ALT) United States $0.046B 0.00
GTx (ONCT) United States $0.045B 0.00
Natural Alternatives (NAII) United States $0.045B 20.34
Onconova Therapeutics (ONTX) United States $0.043B 0.00
MediWound (MDWD) Israel $0.043B 0.00
Aclaris Therapeutics (ACRS) United States $0.042B 0.00
PolarityTE (PTE) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 134.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Forward Pharma (FWP) Denmark $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.037B 0.00
IsoRay (ISR) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.036B 0.00
AgeX Therapeutics (AGE) United States $0.035B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.035B 0.00
Heat Biologics (HTBX) United States $0.033B 0.00
Jaguar Animal Health (JAGX) United States $0.027B 0.00
Mannatechorporated (MTEX) United States $0.026B 8.04
Lipocine (LPCN) United States $0.023B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.023B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.022B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
India Globalization Capital (IGC) United States $0.022B 0.00
Novan (NOVN) United States $0.022B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.020B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.020B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
China SXT Pharmaceuticals (SXTC) China $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.012B 0.00
Cyanotech (CYAN) United States $0.012B 0.00
Vical (BBI) United States $0.012B 0.00
Can-Fite Biopharma (CANF) Israel $0.011B 0.00
Shineco (TYHT) China $0.011B 0.00
KemPharm (KMPH) United States $0.011B 0.00
Regulus Therapeutics (RGLS) United States $0.010B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.003B 0.00
Flex Pharma (SLRX) United States $0.003B 0.00
RXi Pharmaceuticals (PHIO) United States $0.001B 0.00